scholarly article | Q13442814 |
P50 | author | Willem Albert Hanekom | Q71104683 |
Mark Hatherill | Q76888530 | ||
Thomas J Scriba | Q77299176 | ||
Marwou de Kock | Q78566037 | ||
P2093 | author name string | Jonathan Day | |
Robert S Wallis | |||
Bernadette Pienaar | |||
Michael J Brennan | |||
Adam Penn-Nicholson | |||
Erica Smit | |||
E Jane Hughes | |||
Lebohang Makhethe | |||
Lynnett Stone | |||
Michele van Rooyen | |||
Mzwandile Erasmus | |||
Richard Baguma | |||
P2860 | cites work | Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection | Q37347705 |
Novel human in vitro system for evaluating antimycobacterial vaccines | Q37582799 | ||
Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing | Q37626202 | ||
The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays. | Q37678618 | ||
Immunological biomarkers of tuberculosis | Q37862987 | ||
Tuberculosis pathogenesis and immunity | Q37952831 | ||
T cells and adaptive immunity to Mycobacterium tuberculosis in humans | Q38363792 | ||
Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis | Q39625931 | ||
Mycobacterium tuberculosis-specific CD4 T cells are the principal source of IFN-γ in QuantiFERON assays in healthy persons | Q41391483 | ||
IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. | Q41764389 | ||
Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns | Q41775340 | ||
Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model | Q42014279 | ||
Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response | Q42163682 | ||
Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation | Q42226870 | ||
Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells | Q42262934 | ||
A whole blood bactericidal assay for tuberculosis | Q43550213 | ||
Demonstration of increased anti-mycobacterial activity in peripheral blood monocytes after BCG vaccination in British school children | Q45178522 | ||
Failure to control growth of mycobacteria in blood from children infected with human immunodeficiency virus and its relationship to T cell function | Q45723794 | ||
Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa | Q46209425 | ||
Ability of T cell subsets and their soluble mediators to modulate the replication of Mycobacterium bovis in bovine macrophages | Q46515973 | ||
Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb). | Q47630030 | ||
Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. | Q51998139 | ||
Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. | Q52009766 | ||
Cellular responses and Mycobacterium bovis BCG growth inhibition by bovine lymphocytes. | Q54145590 | ||
Tuberculosis | Q56067169 | ||
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge | Q58518610 | ||
PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis | Q58779416 | ||
Evaluation of Human Antimycobacterial Immunity Using Recombinant Reporter Mycobacteria | Q59632141 | ||
In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guérin | Q73942870 | ||
Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects | Q74303707 | ||
Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis | Q77399349 | ||
Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates | Q77823582 | ||
CD4+ T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo | Q79186727 | ||
Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity | Q26862947 | ||
Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization | Q27321593 | ||
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent | Q28191546 | ||
Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3 | Q28298554 | ||
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection | Q29616521 | ||
Disseminated tuberculosis in interferon gamma gene-disrupted mice | Q29619812 | ||
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial | Q29620144 | ||
Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice | Q29622922 | ||
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling | Q30244104 | ||
CD4+ T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ T and CD3- lymphocytes: mechanisms of CD4+ T cell immunity | Q30584398 | ||
Gammadelta T cells and Mycobacterium tuberculosis | Q33912663 | ||
Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIV-status | Q34053275 | ||
SPICE: exploration and analysis of post-cytometric complex multivariate datasets | Q34769778 | ||
Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth | Q34853229 | ||
Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry | Q35117812 | ||
The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents | Q35261953 | ||
A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosets | Q35745991 | ||
Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis | Q35771345 | ||
The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. | Q35772395 | ||
Neutrophil-mediated innate immune resistance to mycobacteria | Q35865371 | ||
Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis | Q35927959 | ||
A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis | Q36103177 | ||
Diversity of disease in childhood pulmonary tuberculosis. | Q36159107 | ||
Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography | Q36171653 | ||
Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine. | Q36302781 | ||
IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination | Q36375426 | ||
Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response | Q36416118 | ||
CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques | Q36419503 | ||
Tuberculosis in Cape Town: An age-structured transmission model | Q36686287 | ||
Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction | Q37033066 | ||
Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa | Q37240761 | ||
Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis | Q37256107 | ||
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG. | Q37335461 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | tuberculosis | Q12204 |
whole blood | Q7997549 | ||
Mycobacterium tuberculosis | Q130971 | ||
P304 | page(s) | e0184563 | |
P577 | publication date | 2017-09-08 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population | |
P478 | volume | 12 |
Q64069523 | A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates |
Q64079014 | An Auto-luminescent Fluorescent BCG Whole Blood Assay to Enable Evaluation of Paediatric Mycobacterial Responses Using Minimal Blood Volumes |
Q88874314 | Friends and foes of tuberculosis: modulation of protective immunity |
Q52376102 | Mycobacterial growth inhibition is associated with trained innate immunity. |
Q91644903 | The tyrosine kinase inhibitor dasatinib reduces the growth of intracellular Mycobacterium tuberculosis despite impairing T-cell function |
Search more.